# Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension

> **NCT00641836** · NA · COMPLETED · sponsor: **Zhejiang University** · enrollment: 98 (actual)

## Conditions studied

- Idiopathic Pulmonary Arterial Hypertension

## Interventions

- **PROCEDURE:** Transplantation of autologous endothelial progenitor cells

## Key facts

- **NCT ID:** NCT00641836
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2008-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641836, "Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00641836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*